Antares Pharma Forecast and Stock Analysis
Technical ATRS stock analysis for April 24, 2019.
Antares Pharma fell by -2.13% in the last day from $2.82 to $2.76 The price has fallen in 6 of the last 10 days and is down by -5.8% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -158 439 shares and in total 441 564 shares bought and sold for approximately $1.22 million.
Close price at the end of the last trading day (Wednesday, 24th Apr 2019) of the ATRS stock was $2.76. This is 2.13% less than the trading day before Tuesday, 23rd Apr 2019.
During day the stock fluctuated 4.26% from a day low at $2.75 to a day high of $2.87.
30 day high of the ATRS stock price was $3.14 and low was $2.60.
90 day high was $3.96 and low was $2.60.
52 week high for the Antares Pharma - $3.96 and low - $2.16.
Antares Pharma lies in the lower of a very wide and falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $2.60 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -10.06% during the next 3 months and, with 90% probability hold a price between $2.34 and $3.29 at the end of this period.
There are few to none technical positive signals at the moment. Antares Pharma holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $2.76 and $3.13. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Tuesday April 23, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Relative Strength Index (RSI)
RSI14 is 38 and the stock is currently not being overbought or oversold
Support & Resistance
Antares Pharma finds support from accumulated volume at $2.75.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.12 between high and low, or 4.26%. For the last week the stock has had a daily average volatility of 5.28%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
Antares Pharma holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|ATRS $2.76 ($-0.06 -2.13%)|
ATRS is down $0.06 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ATRS based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ATRS analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us